Resources | NITAG RESOURCE CENTER

2023

E-NITAG Recommendation on single-dose HPV vaccination

2023

Updated HPV Technical Dossier on Quadrivalent HPV (Gardasil-4valent) 1-dose Regimen

2022 ∙ Wang, D. Wu, J. Du, J. Ong, H. Tang, B. Dozier, M. Weller, D. Campbell, C.

Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature

2022 ∙ Tran, P. T. Riaz, M. Chen, Z. Truong, C. B. Diaby, V.

An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines

2022 ∙ Cotache-Condor, C. Peterson, M. Asare, M.

Application of theoretical frameworks on human papillomavirus vaccine interventions in the United States: systematic review and meta-analysis

2022 ∙ Ssentongo, P. McCall-Hosenfeld, J. S. Calo, W. A. Moss, J. Lengerich, E. J. Chinchilli, V. M. Ba, D. M.

Association of human papillomavirus vaccination with cervical cancer screening: A systematic review and meta-analysis

2022 ∙ Gopalani, S. V. Sedani, A. E. Janitz, A. E. Clifton, S. C. Peck, J. D. Comiford, A. Campbell, J. E.

Barriers and Factors Associated with HPV Vaccination Among American Indians and Alaska Natives: A Systematic Review

2022 ∙ Constable, C. Ferguson, K. Nicholson, J. Quinn, G. P.

Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review

2022 ∙ Akumbom, A. M. Lee, J. J. Reynolds, N. R. Thayer, W. Wang, J. Slade, E.

Cost and effectiveness of HPV vaccine delivery strategies: A systematic review

2022 ∙ Zhang, X. Tang, L.

Cultural adaptation in HPV vaccine intervention among racial and ethical minority population: a systematic literature review